Mixing Vaccines for Boosters?

970 Views | 2 Replies | Last: 3 yr ago by bigtruckguy3500
AgLiving06
How long do you want to ignore this user?
On another site I'm on, a doctor was talking about that if you get a booster, you should get another "type" of shot as a booster.

His reasoning was the following:

"The viral vectors like JnJ & Astrazenica produce a slightly better T-cell response than Pfizer/Moderna, which produce a slightly better B-cell response. By mixing them you reach an optimal response of both"

He then posted this chart with the following explanation:



"okay so this is a series of comparisons.

Left is Jnj followed by Jnj.
Right is pfizer followed by pfizer.
Middle is Jnj followed by pfizer.

Each square is looking at a different immune response.

Top left is # of antibodies that you make.

Top right is helper T-cell response, very important because they're the field generals who coordinate immunity.

Bottom left is the percentage of antibodies that induce neutralization of the spike protein.

Bottom right is the one to focus on. It's the # of CD8 T-cells, which are the T-cells that you use to fight viruses. Mixing Jnj and Pfizer produce a better CD8 response than any other combination."





dubi
How long do you want to ignore this user?
AG
I was wondering about this; thanks for posting.
Aggie95
How long do you want to ignore this user?
AG
I wondered the same. I got Moderna and wonder if Pfizer booster would offer better results
bigtruckguy3500
How long do you want to ignore this user?
The best booster will probably be a live attenuated nasal mist vaccine. But as far as I know, none are likely to reach the market anytime soon.

But unless you're immunocompromised, or high risk, I'd probably not worry about a booster for at least another few months.

Also, keep in mind that if you're ever exposed to someone with COVID, that is like a booster (probably the best kind of booster).
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.